{"DataElement":{"publicId":"7238944","version":"1","preferredName":"Tumor Mass Thyroid Carcinoma Histologic Type","preferredDefinition":"The type of tissue in which a carcinoma arising from the thyroid gland originated.","longName":"6796606v1.0:7238880v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7238880","version":"1","preferredName":"Thyroid Carcinoma Histologic Type","preferredDefinition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"7238880v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Papillary Thyroid Carcinoma, Oncocytic Variant","valueDescription":"Oncocytic Neoplasm","ValueMeaning":{"publicId":"3251524","version":"1","preferredName":"Oncocytic Neoplasm","longName":"3251524","preferredDefinition":"A usually benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm.  Representative examples include oncocytic neoplasms of the thyroid gland, and kidney. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncocytic Neoplasm","conceptCode":"C7072","definition":"A usually benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm.  Representative examples include oncocytic neoplasms of the thyroid gland, and kidney. (NCI05)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A766EF05-0938-69EE-E040-BB89AD437928","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2537FD5-B8EC-71B8-E053-F662850A22B3","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","deletedIndicator":"No"},{"value":"Papillary Thyroid Carcinoma, Columnar Variant","valueDescription":"Clear Cell Variant Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"7238882","version":"1","preferredName":"Clear Cell Variant Thyroid Gland Papillary Carcinoma","longName":"7238882","preferredDefinition":"A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells.  These cells have the nuclear features that characterize the papillary carcinomas of the thyroid gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Variant Thyroid Gland Papillary Carcinoma","conceptCode":"C46094","definition":"A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells.  These cells have the nuclear features that characterize the papillary carcinomas of the thyroid gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2537FD5-B8FA-71B8-E053-F662850A22B3","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2537FD5-B913-71B8-E053-F662850A22B3","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","deletedIndicator":"No"},{"value":"Papillary Thyroid Carcinoma, Follicular Variant","valueDescription":"Follicular Variant Thyroid Gland Papillary Carcinoma Follicular Variant Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"7238884","version":"1","preferredName":"Follicular Variant Thyroid Gland Papillary Carcinoma Follicular Variant Thyroid Gland Papillary Carcinoma","longName":"7238884","preferredDefinition":"An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.: An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Variant Thyroid Gland Papillary Carcinoma","conceptCode":"C126594","definition":"An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Follicular Variant Thyroid Gland Papillary Carcinoma","conceptCode":"C126594","definition":"An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2537FD5-B922-71B8-E053-F662850A22B3","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2537FD5-B93B-71B8-E053-F662850A22B3","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","deletedIndicator":"No"},{"value":"Papillary Thyroid Carcinoma, NOS","valueDescription":"Thyroid, NOS","ValueMeaning":{"publicId":"6779703","version":"1","preferredName":"Thyroid, NOS","longName":"6779703","preferredDefinition":"An area of the thyroid gland not otherwise specified. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid, NOS","conceptCode":"C160209","definition":"An area of the thyroid gland not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-798F-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"SOKKERL","dateModified":"2019-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2537FD5-B95A-71B8-E053-F662850A22B3","beginDate":"2019-08-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80C73DE-393A-758F-E053-4EBD850A86BE","beginDate":"2019-08-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7238879","version":"1","preferredName":"Thyroid Gland Carcinoma Histologic Type Type","preferredDefinition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4815:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2537FD5-B8BA-71B8-E053-F662850A22B3","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"ONEDATA","dateModified":"2020-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2537FD5-B8CB-71B8-E053-F662850A22B3","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"KNABLEJ","dateModified":"2020-06-14","changeDescription":"6/14/20 jk upd Other PV to use CPTAC CUI for \"Other Histologic Type\".   4/8/20 jk Released per SME review and approval.  4/2/20 jk created for CPTAC THCA baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779571","version":"1","longName":"THCA Baseline","context":"OCCPR"},{"publicId":"6779572","version":"1","longName":"THCA Local Pathology","context":"OCCPR"},{"publicId":"6779573","version":"1","longName":"THCA Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A253ECD1-1BD3-70F3-E053-F662850AD9DB","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-02","modifiedBy":"KNABLEJ","dateModified":"2020-04-27","changeDescription":"4/27/20 jk Released per SME 4/8/20 review and approval.  4/2/20 jk  created for CPTAC THCA baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}